{
    "organizations": [],
    "uuid": "d3d586c7a3175260de3ac27f24c5b31c0e209a7c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sobi-says-fda-grants-fast-track-st/brief-sobi-says-fda-grants-fast-track-status-for-sobi003-drug-candidate-idUSFWN1PI0F9",
    "ord_in_thread": 0,
    "title": "BRIEF-Sobi says FDA grants fast track status for SOBI003 drug candidate",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 23 (Reuters) - Swedish Orphan Biovitrum:\n* FDA ACCEPTS INVESTIGATIONAL NEW DRUG APPLICATION AND GRANTS FAST TRACK STATUS FOR SOBI003 FOR THE TREATMENT OF MPS IIIA\n* SAYS ‍CLINICAL STUDY WITH SOBI003 IS EXPECTED TO START DURING 2018​ Source text for Eikon: Further company coverage: (Stockholm Newsroom)\n ",
    "published": "2018-01-23T16:06:00.000+02:00",
    "crawled": "2018-01-24T15:47:34.077+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "swedish",
        "orphan",
        "biovitrum",
        "fda",
        "accepts",
        "investigational",
        "new",
        "drug",
        "application",
        "grant",
        "fast",
        "track",
        "status",
        "sobi003",
        "treatment",
        "mp",
        "iiia",
        "say",
        "study",
        "sobi003",
        "expected",
        "start",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "stockholm",
        "newsroom"
    ]
}